Nytol One-A-Night (Diphenhydramine Hydrochloride)

Diphenhydramine Hydrochloride, the active ingredient in Nytol One-A-Night, is a first‑generation H1 antihistamine presented as an oral tablet for oral use. It is indicated for short‑term treatment of occasional insomnia in adults. GNH USA supplies Nytol One-A-Night as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Diphenhydramine acts on the histamine pathway to alleviate sleep disturbances. - Occasional insomnia: facilitates falling asleep for short periods. - Transient sleep disturbance: helps restore a normal sleep pattern. - Sleep onset difficulty: promotes quicker sleep onset.

Common Side Effects: - Drowsiness: persistent sleepiness during daytime. - Dry mouth: reduced salivation leading to throat discomfort. - Blurred vision: temporary visual disturbances. - Constipation: slowed gastrointestinal motility. - Urinary retention: difficulty initiating urination. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, angioedema, or anaphylaxis. - Severe CNS depression: profound sedation impairing daily activities. - Cardiac arrhythmias: irregular heartbeats, especially in predisposed individuals. - Confusion or hallucinations: altered mental status, more common in the elderly. - Respiratory depression: difficulty breathing in high doses.

Before using Nytol One-A-Night, consider the following precautions: - Assess need for sedation: limit use to short‑term insomnia. - Avoid operating machinery: potential impairment of alertness. - Use caution in elderly: increased anticholinergic sensitivity. - Avoid alcohol: additive central nervous system depression. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at ambient temperature: keep in the original pack, protect from moisture.

Diphenhydramine may interact with several drug classes. Major Interactions (Avoid): - Alcohol: additive CNS depression leading to excessive sedation. - Other sedatives (benzodiazepines, opioids): heightened risk of profound drowsiness. - Monoamine oxidase inhibitors: potential severe central nervous system effects. Moderate Interactions (Monitor Closely): - Anticholinergic drugs: enhanced anticholinergic burden causing dry mouth, constipation. - CYP2D6 inhibitors (e.g., fluoxetine): may increase diphenhydramine plasma levels. - Other antihistamines: additive sedation and anticholinergic effects.